Tuesday, August 30, 2016

Roth downgrades TearLab to neutral

Roth downgrades TearLab to neutral

August 4, 2016 by · Leave a Comment 

Tweet Roth Capital Partners downgraded TearLab (NASDAQ:TEAR; TSX:TLB) to “neutral” from “buy,” citing sales transition challenges. The stock closed at 83 cents on Wednesday. Analyst Chris Lewis writes that TearLab’s second quarter year-over-year growth of 9% was the lowest since the first quarter of 2012, prompting the company to once again lower its 2016 outlook. […]

TearLab Q1 revenue climbs 25%

TearLab Q1 revenue climbs 25%

May 4, 2016 by · Leave a Comment 

Tweet First quarter revenue for TearLab (NASDAQ:TEAR; TSX:TLB) rose 25% to $6.8-million from $5.4-million a year ago. A net total of 257 TearLab Osmolarity Systems were added in the first quarter of 2016, of which 167 were under the company’s new Flex program and 61 were purchased outside of the U.S. “While we had to […]

TearLab prices $17.3-million registered public offering

TearLab prices $17.3-million registered public offering

May 4, 2016 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has priced a public offering of common stock to raised gross proceeds of approximately $17.3-million to close on May 9. The offering was priced at 75 cents a share of common stock, or common stock equivalent, with each share of common stock coupled with a warrant to purchase one-half of one […]

TearLab Q4 revenue climbs 28%

TearLab Q4 revenue climbs 28%

March 8, 2016 by · Leave a Comment 

Tweet Fourth quarter revenue for TearLab (NASDAQ:TEAR; TSX:TLB) was $6.8-million, up 28% from $5.3-million a year ago. For all of 2015, revenue rose 28% to $25.2-million from $19.7-million for 2014. A net total of 258 TearLab Osmolality Systems were added in the fourth quarter of 2015, of which 200 were under the company’s new Flex […]

TearLab Q3 revenue climbs 27%

TearLab Q3 revenue climbs 27%

November 5, 2015 by · Leave a Comment 

Tweet Third quarter revenue for TearLab (NASDAQ:TEAR; TSX:TLB) rose 27% to $6.6-million from $5.2-million a year ago. A net total of 228 TearLab systems were added in the third quarter. “We delivered a strong growth quarter both sequentially and compared with the prior year by expanding our device base and continuing to establish the clinical […]

TearLab names Wes Brazell as CFO

TearLab names Wes Brazell as CFO

July 6, 2015 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has appointed Wes Brazell as CFO, with overall responsibility for operational finance, financial reporting, budgeting and strategic planning, as well as helping to manage the company’s relationships and interactions with the investment community. He  succeeds William Dumencu, who will continue to support the company in a consulting role until the end […]

TearLab posts 28% increase in Q1 revenue

TearLab posts 28% increase in Q1 revenue

May 7, 2015 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) reported first quarter net revenue of $5.4-million, up 28% from $4.2-million for the same period in 2014. A total of 261 orders for TearLab systems were booked in the first quarter. “We started 2015 with a fully staffed sales force, a better understanding of implementation, and, as evidenced by the continuing […]

TearLab in $35-million loan agreement with CRG

TearLab in $35-million loan agreement with CRG

March 5, 2015 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has entered into a term loan agreement with CRG and certain of its affiliate funds, which provides TearLab with up to $35-million of available borrowing capacity. Under the accord, CRG is initially providing TearLab with $15-million. Up to $20-million of additional funding will be available to TearLab, at its option, through […]

TearLab to unveil second generation tear testing platform

TearLab to unveil second generation tear testing platform

August 14, 2014 by · Leave a Comment 

Tweet At its analyst and investor day on Sept. 23, TearLab (NASDAQ:TEAR; TSX:TLB) plans to cover its current business and growth strategies, international market opportunities recent R&D activities, including development of a second-generation point-of-care tear testing platform. On the second quarter conference call earlier this month, CEO Elias Vamvaskas said most of the research has been […]

TearLab Q2 revenue climbs 42%

TearLab Q2 revenue climbs 42%

August 7, 2014 by · Leave a Comment 

Tweet TearLab (NASDAQ:TEAR; TSX:TLB) has reported second quarter revenue of $5-million, up 42% from $3.5-million in the year earlier quarter and an increase of 19% sequentially from $4.2-million in the 2014 first quarter. A net 171 TearLab Osmolarity systems were added to the company’s installed base in the second quarter. Of those, 126 systems were […]

Next Page »

Email Newsletters with Constant Contact
Google+